These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27103788)

  • 1. Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review.
    Song X; Shi K; Zhou SJ; Yu DP; Liu Z; Han Y
    Drug Des Devel Ther; 2016; 10():1345-54. PubMed ID: 27103788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Retinoic acid receptor-β hypermethylation and NSCLC risk: a meta-analysis and literature review.
    Li Y; Lu DG; Ma YM; Liu H
    Oncotarget; 2017 Jan; 8(4):5814-5822. PubMed ID: 28008143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of the relationship between RARβ gene promoter methylation and non-small cell lung cancer.
    Hua F; Fang N; Li X; Zhu S; Zhang W; Gu J
    PLoS One; 2014; 9(5):e96163. PubMed ID: 24796328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer.
    Dutkowska A; Antczak A; Pastuszak-Lewandoska D; Migdalska-Sek M; Czarnecka KH; Górski P; Kordiak J; Nawrot E; Brzeziańska-Lasota E
    Adv Exp Med Biol; 2016; 878():29-38. PubMed ID: 26453065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis.
    Xu L; Lan H; Su Y; Li J; Wan J
    Drug Des Devel Ther; 2015; 9():2855-65. PubMed ID: 26082616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review.
    Guo H; Zhou S; Tan L; Wu X; Wu Z; Ran R
    Oncotarget; 2017 Jan; 8(2):2550-2557. PubMed ID: 27911280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between RARbeta gene promoter methylation and P53 gene mutations in non-small cell lung cancer].
    Tan C; Jin YT; Xu HY; Zhang CY; Zhang H; Zhang WM; Chen CM; Sun XY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):131-6. PubMed ID: 22487818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
    Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
    J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysis.
    Chen Z; Fan Y; Liu X; Shang X; Qi K; Zhang S
    Int J Biol Markers; 2022 Mar; 37(1):47-57. PubMed ID: 34935548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
    Wang Z; Wang B; Guo H; Shi G; Hong X
    Drug Des Devel Ther; 2015; 9():207-16. PubMed ID: 25565774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
    Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH
    J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
    Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
    Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim YT; Lee SH; Sung SW; Kim JH
    Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis.
    Wen G; Wang H; Zhong Z
    Medicine (Baltimore); 2018 Mar; 97(11):e9971. PubMed ID: 29538221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
    Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review.
    Yan W; Xu N; Han X; Zhou XM; He B
    Sci Rep; 2016 Jan; 6():19303. PubMed ID: 26796853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of methylation of the RAR-β gene with cigarette smoking in non-small cell lung cancer with Southern-Central Chinese population.
    Li W; Deng J; Wang SS; Ma L; Pei J; Zeng XX; Tang JX
    Asian Pac J Cancer Prev; 2014; 15(24):10937-41. PubMed ID: 25605205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review.
    Wu X; Wu G; Yao X; Hou G; Jiang F
    Drug Des Devel Ther; 2016; 10():699-709. PubMed ID: 26929601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer.
    Muñiz-Hernández S; Huerta-Yepez S; Hernández-Pedro N; Ramírez-Tirado LA; Aviles-Salas A; Maldonado A; Hernández-Cueto D; Baay-Guzmán G; Arrieta O
    Int J Clin Oncol; 2016 Dec; 21(6):1051-1061. PubMed ID: 27306217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC).
    Feng H; Zhang Z; Qing X; Wang X; Liang C; Liu D
    Exp Mol Pathol; 2016 Feb; 100(1):109-13. PubMed ID: 26681652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.